Success Stories: Remarkably, a Research Fellow Working in the Cancer Immunotherapy Field Obtained NIW approval Just 3 days After NAILG Filed the Petition with the USCIS
Client’s Testimonial:
“I want to express my sincere appreciation for your assistance and guidance throughout the application process. Your knowledge and expertise made a profound difference in the outcome of my case. I am deeply grateful for your exceptional legal representation and grateful to have had you in my corner.”
On October 19th, 2023, we received another EB-2 NIW (National Interest Waiver) approval for a Research Fellow in the Field of Cancer Immunotherapy (Approval Notice).
General Field: Cancer Immunotherapy
Position at the Time of Case Filing: Research Fellow
Country of Origin: Taiwan
State of Residence at the Time of Filing: Maryland
Approval Notice Date: October 19th, 2023
Processing Time: 3 days (Premium Processing Requested)
Case Summary:
With the help of our team at the North America Immigration Law Group, one of our clients, a research fellow with a Ph.D. in biochemistry and molecular biology received an approval notice for her NIW (National Interest Waiver) petition.
Our client hired us because she was aware of the complexity of the green card application process. Following the execution of the attorney-client agreement, our vigilant team helped her put together a strong NIW petition package and offered all the required guidance. We carefully assembled the NIW petition packet for our client, making sure it contained all the necessary data for the USCIS to review. The completed file was then sent to the USCIS. Therefore, the petition was approved in just 3 days because of the premium processing service.
A couple of the things that we included in her NIW petition file are listed below:
- Firstly, we documented that she published 9 peer-reviewed journal articles (1 of them first-authored), and these papers have been published in the top journals in her chosen field, reflecting her peers’ recognition of the value of this research.
- Moreover, she has published these papers in no fewer than 5 highly-ranked peer-reviewed journals, confirming that her record of successful research has well-positioned her to continue advancing the proposed endeavor of developing a multi-disciplinary screening platform to characterize drugs and biological molecules for immune system interventions to reprogram the tumor microenvironment and enhance the efficacy of cancer immunotherapy.
- Not only has she completed and published the results of her research in the field, but her research has also gone on to influence her peers. That is, her publications have been cited a total of 220 times, thereby demonstrating they are highly regarded and consulted in the field of cancer immunotherapy.
- In addition, when we assessed the research, she plans to pursue, we concluded that it will be of great importance because it enhances the power of cancer immunotherapy drugs, providing cancer patients with better prognoses.
With her track record of successful research in an area that greatly advances U.S. interests, she offers contributions of such value that, even under the assumption that other qualified U.S. workers are available, she would benefit the United States overall. In order to improve the efficacy of cancer immunotherapy, her proposed endeavor will directly address important issues related to novel immunotherapy and screening techniques for improved precision medicine treatments against cancer.
We are incredibly appreciative to our client for choosing our law firm to help her in presenting her NIW petition. Given her demonstrated proficiency in the field of cancer immunotherapy, maintaining and advancing US technological supremacy depends on her ongoing efforts. As a result, USCIS successfully approved her national interest waiver petition, recognizing that the goals of the country today are aligned with her scientific accomplishments in the field of cancer immunotherapy and demonstrating the clear necessity of her ongoing research here in the United States.